PharmaCielo Ltd.
PCLO.V
TSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 70.12% | 221.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 70.12% | 221.38% | |||
| Cost of Revenue | 88.71% | -21.51% | |||
| Gross Profit | 35.76% | 167.93% | |||
| SG&A Expenses | -35.10% | 50.43% | |||
| Depreciation & Amortization | -5.68% | -46.76% | |||
| Other Operating Expenses | -65.63% | -788.89% | |||
| Total Operating Expenses | -9.62% | 21.70% | |||
| Operating Income | 47.27% | 5.91% | |||
| Income Before Tax | -2.99% | -4.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.99% | -4.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.99% | -4.84% | |||
| EBIT | 47.27% | 5.91% | |||
| EBITDA | 48.03% | 3.57% | |||
| EPS Basic | -8.11% | -4.72% | |||
| Normalized Basic EPS | 24.64% | -1.47% | |||
| EPS Diluted | -8.11% | -4.72% | |||
| Normalized Diluted EPS | 24.64% | -1.47% | |||
| Average Basic Shares Outstanding | -4.55% | 0.27% | |||
| Average Diluted Shares Outstanding | -4.55% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||